121 related articles for article (PubMed ID: 16117947)
21. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
Drent M; Jacobs JA; de Vries J; Lamers RJ; Liem IH; Wouters EF
Eur Respir J; 1999 Jun; 13(6):1338-44. PubMed ID: 10445609
[TBL] [Abstract][Full Text] [Related]
22. Analysis of T cell subsets and beta chemokines in patients with pulmonary sarcoidosis.
Iida K; Kadota J; Kawakami K; Matsubara Y; Shirai R; Kohno S
Thorax; 1997 May; 52(5):431-7. PubMed ID: 9176534
[TBL] [Abstract][Full Text] [Related]
23. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases].
Schildge J; Klar B; Hardung-Backes M
Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558
[TBL] [Abstract][Full Text] [Related]
24. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis.
Kantrow SP; Meyer KC; Kidd P; Raghu G
Eur Respir J; 1997 Dec; 10(12):2716-21. PubMed ID: 9493649
[TBL] [Abstract][Full Text] [Related]
25. Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile?
Drent M; Grutters JC; Mulder PG; van Velzen-Blad H; Wouters EF; van den Bosch JM
Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):31-8. PubMed ID: 9186987
[TBL] [Abstract][Full Text] [Related]
26. Significance of the interleukin-1 receptor antagonist/interleukin-1 beta ratio as a prognostic factor in patients with pulmonary sarcoidosis.
Mikuniya T; Nagai S; Takeuchi M; Mio T; Hoshino Y; Miki H; Shigematsu M; Hamada K; Izumi T
Respiration; 2000; 67(4):389-96. PubMed ID: 10940792
[TBL] [Abstract][Full Text] [Related]
27. Sarcoidosis activates diverse transcriptional programs in bronchoalveolar lavage cells.
Gharib SA; Malur A; Huizar I; Barna BP; Kavuru MS; Schnapp LM; Thomassen MJ
Respir Res; 2016 Jul; 17(1):93. PubMed ID: 27460362
[TBL] [Abstract][Full Text] [Related]
28. Bronchoalveolar lavage quality influences the T4/T8 ratio in sarcoidosis.
Reichenberger F; Kleiber B; Baschiera B; Bubendorf L; Brutsche M; Dalquen P; Tamm M
Respir Med; 2007 Sep; 101(9):2025-30. PubMed ID: 17587560
[TBL] [Abstract][Full Text] [Related]
29. Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis.
Osińska I; Wołosz D; Domagała-Kulawik J
Pol Arch Med Wewn; 2014; 124(7-8):359-64. PubMed ID: 24824543
[TBL] [Abstract][Full Text] [Related]
30. [Sarcoidosis and tobacco smoking--clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition].
Urbankowski T; Knyziak-Medrzycka I; Domagała-Kulawik J; Chazan R
Pol Merkur Lekarski; 2012 May; 32(191):298-301. PubMed ID: 22779335
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of Ia+ T lymphocytes in bronchoalveolar lavage fluid in pulmonary sarcoidosis.
Suzuki K; Tamura N; Iwase A; Dambara T; Kira S
Am J Respir Crit Care Med; 1996 Sep; 154(3 Pt 1):707-12. PubMed ID: 8810609
[TBL] [Abstract][Full Text] [Related]
32. The yield of endobronchial biopsy in pulmonary sarcoidosis: connection between spirometric impairment and lymphocyte subpopulations in bronchoalveolar lavage fluid.
Kieszko R; Krawczyk P; Michnar M; Chocholska S; Milanowski J
Respiration; 2004; 71(1):72-6. PubMed ID: 14872114
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of bronchoalveolar lavage lymphocyte count in recently diagnosed pulmonary sarcoidosis.
Laviolette M; La Forge J; Tennina S; Boulet LP
Chest; 1991 Aug; 100(2):380-4. PubMed ID: 1864110
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic granulocyte and monocyte apheresis (GMA) for treatment refractory sarcoidosis: a pilot study of clinical effects and possible mechanisms of action.
Olsen HH; Muratov V; Cederlund K; Lundahl J; Eklund A; Grunewald J
Clin Exp Immunol; 2014 Sep; 177(3):712-9. PubMed ID: 24773420
[TBL] [Abstract][Full Text] [Related]
35. An analysis of the inter-relationships among multiple bronchoalveolar lavage and serum determinations, physiologic tests, and clinical disease activity in patients with sarcoidosis.
Rankin JA; Huang SS; Sostman HD; Gee JB; Reynolds HY
Sarcoidosis; 1991 Mar; 8(1):19-28. PubMed ID: 1669934
[TBL] [Abstract][Full Text] [Related]
36. Activation of peripheral blood mononuclear cells in bronchoalveolar lavage fluid from patients with sarcoidosis: visualisation of single cell activation products.
Pantelidis P; Southcott AM; Cambrey AD; Laurent GJ; du Bois RM
Thorax; 1994 Nov; 49(11):1146-51. PubMed ID: 7831632
[TBL] [Abstract][Full Text] [Related]
37. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis.
Hoheisel GB; Tabak L; Teschler H; Erkan F; Kroegel C; Costabel U
Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):460-3. PubMed ID: 8306046
[TBL] [Abstract][Full Text] [Related]
38. Bronchoalveolar lavage impact in sarcoidosis: study of 40 cases.
Bacha D; Ayadi-Kaddour A; Ismail O; El Mezni F
Tunis Med; 2009 Jan; 87(1):38-42. PubMed ID: 19522425
[TBL] [Abstract][Full Text] [Related]
39. [Comparative analysis of bronchoalveolar lavages in interstitial lung diseases].
Song KS; Heo WB; Won DI
Korean J Lab Med; 2007 Jun; 27(3):221-7. PubMed ID: 18094580
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Wahlström J; Berlin M; Sköld CM; Wigzell H; Eklund A; Grunewald J
Thorax; 1999 Apr; 54(4):339-46. PubMed ID: 10092696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
